Actively Recruiting

Phase Not Applicable
Age: 50Years +
All Genders
NCT05465070

Leg Heat Therapy in Peripheral Artery Disease

Led by Indiana University · Updated on 2026-01-06

106

Participants Needed

1

Research Sites

216 weeks

Total Duration

On this page

Sponsors

I

Indiana University

Lead Sponsor

P

Purdue University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this randomized, double-blind, sham-controlled clinical trial is to evaluate the benefits of home-based, leg heat therapy (HT) on lower-extremity functioning and quality of life in patients who suffer from lower-extremity peripheral artery disease (PAD). We will randomize 106 patients to one of two groups that either receive leg HT or a sham intervention. The primary study outcome is the change in 6-minute walk distance between baseline and the 12-week follow up. Secondary outcomes include changes in the short physical performance battery score, handgrip strength, quality of life (measured by the Walking Impairment Questionnaire and Short-Form (SF)-36 Questionnaire), calf muscle strength (measured using a calf ergometer), size (measured by magnetic resonance imaging) and bioenergetics (assessed using phosphorus-31 magnetic resonance spectroscopy), and physical activity (measured by accelerometer).

CONDITIONS

Official Title

Leg Heat Therapy in Peripheral Artery Disease

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women older than 50 years
  • Resting ankle-brachial index (ABI) of 0.9 or less in at least one leg
  • Individuals with resting ABI between 0.91 and 1.00 eligible if ABI drops by 20% or more after a heel-rise test
Not Eligible

You will not qualify if you...

  • Critical limb ischemia with rest pain or non-healing wounds
  • Prior foot or leg amputation
  • Exercise tolerance limited by conditions other than leg pain (e.g., angina, arthritis, severe lung disease)
  • Lower-extremity revascularization or orthopedic surgery within last 3 months
  • Use of walking aid other than a cane
  • Active cancer
  • Chronic kidney disease with eGFR below 30
  • Class 2 or 3 obesity (BMI 35 or higher)
  • Unable to fit into water-circulating trousers
  • Mini-Mental Status Examination score below 23
  • Impaired thermal sensation in the leg
  • Contraindications to MRI including certain implanted devices, claustrophobia, or inability to lie flat or fit in scanner

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Indiana University Health Methodist Hospital

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

K

Kimmy Marshall, RN

CONTACT

B

Bruno Roseguini, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here